课题基金 / 基金详情

High throughput small molecule screening with 3D lung-mimetic hydrogels in the rare lung disease Lymphangioleiomyomatosis

High throughput small molecule screening with 3D lung-mimetic hydrogels in the rare lung disease Lymphangioleiomyomatosis
使用 3D 拟肺水凝胶对罕见肺部疾病淋巴管平滑肌瘤病进行高通量小分子筛选
批准号:
411850
负责人:
Pietrobon Adam
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01
关键词:

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lymphangioleiomyomatosis (LAM) is a rare lung disease that predominantly strikes women during reproductive years. In patients, aggressive LAM cells invade the lungs, causing destruction of essential tissue and leading to respiratory failure. LAM is driven
期刊论文(0)
专著(0)
科研奖励(0)
会议论文